Samsung is importing one million innovative Low Dead Space (LDS) syringes to support India’s Covid vaccination drive. This is part of the Company’s Covid Support program for the country. LDS syringes minimize the amount of drug left in the syringes after an injection, reducing vaccine wastage, and thereby enabling 20% more people to get the dose with the same amount of vaccine.
LDS syringes, airlifted from South Korea, have been delivered to Uttar Pradesh – 325,000 each to the district administrations in Lucknow and Noida – while 350,000 LDS syringes will soon be handed over to the Greater Chennai Corporation in Tamil Nadu. These syringes will be deployed at Covid Vaccination Centres in the districts.
The technology behind LDS syringes has demonstrated up to 20% greater efficiency. That means if existing syringes were to deliver one million doses, LDS syringes could deliver 1.2 million doses with the same amount of vaccine. Samsung has helped the manufacturer of these syringes increase production capacity.
This innovative syringe has been introduced for usage in a few markets including the United States to optimize vaccination.
Samsung has pledged USD 5 million (INR 37 Crores) as its contribution to India’s fight against Covid-19, providing donations to central and state governments, and boosting the healthcare sector with essential medical equipment for hospitals, as part of its citizenship initiatives. Samsung’s contribution includes USD 2 million worth of medical supplies, including 100 Oxygen Concentrators, 3,000 Oxygen Cylinders and one million LDS syringes.